Novartis BiopharmOPS Singapore

Novartis BiopharmOPS Singapore

Singapore is becoming increasingly important as a location due to its proximity to the expanding Asian markets. In the industrial zone, in the western part of the city-state, numerous pharmaceutical companies have established themselves, including among others, the Swiss pharmaceutical group Novartis, from Basel. Here the group is creating a new production location including an administration building for the manufacture of biotech medicines. This places particular demands on the facade. The cladding elements must satisfy clean room requirements in relation to the interiors.

Project: Novartis BiopharmOPS Singapore

Client: Novartis Pharmaceutical Manufacturing Pte Ltd.

ArchitectJacobs Engineering Singapore Pte Ltd.

Technical Engineer: Schneeberger Fassadenmanagement GmbH

Year of construction: 2013 - 2014

Scope of services: Approx. 10,000 m² element facade (in part with rigid sunshade in the interspace between the panes), approx. 3,500 m² aluminium cold facade approx. 5,500 m² standing seam roof